Several studies have confirmed that CCNB1 can be used as a diagnostic or prognostic biomarker for rhabdomyosarcoma, hepatocellular carcinoma, and meningioma [36–38]. The gene discussed is CCNB1; the disease is hepatocellular carcinoma.